Ascena Retail Group Inc. (NASDAQ: ASNA) posted a new 52-week low on Friday of $11.52. Based on Thursday night’s closing price of $11.91 that’s a drop of about 3.3%. The stock’s 52-week high is $23.14. Trading was about equal to the stock’s average daily volume of around 2 million shares traded. The specialty retailer had no specific news today..
Finish Line Inc. (NASDAQ: FINL) dropped nearly 22% Friday to post a new 52-week low of $22.62. The stock’s 52-week high is $31.90. Volume rose to about 7-times the daily average of around 900,000 shares. The shoe retailer posted a quarterly loss this morning and lowered its outlook.
ImmunoGen Inc. (NASDAQ: IMGN) dropped more than 50% on Friday to post a new 52-week low of $5.36 after closing at $10.85 on Thursday. The stock’s 52-week high is $17.80. Share volume is about 14-times the 1.2 million daily average shares traded. The company’s stock took a beating following a report from Roche Holdings of disappointing results in a trial of a breast cancer treatment.
Stratasys Ltd. (NASDAQ: SSYS) posted a drop of about 2.6% Friday after dropping 5% on Thursday to establish another new 52-week low at $76.60 against a high of $138.10. Volume was about 20% higher than the daily average of around 1.3 million shares. The company had no specific news again today.
ALSO READ: Beers Americans No Longer Drink
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.